Kamal Ghorui
The question of how a society treats life at its most fragile stage has always tested the moral and legal conscience of nations. The recent order of the Supreme Court of India allowing the withdrawal of life-sustaining treatment for a 32-year-old man who had remained in a persistent vegetative state for thirteen years has reignited a vital national conversation on dignity, compassion and the limits of medical intervention.
In a significant ruling, a Bench comprising Justice JB Pardiwala and Justice KV Viswanathan permitted the withdrawal of artificial life support for Harish Rana, who had suffered catastrophic brain injury after falling from the fourth floor of his paying guest accommodation. The injury left him with complete quadriplegia and an irreversible persistent vegetative state. For more than a decade he survived only through clinically administered nutrition via surgically inserted PEG tubes, with medical reports consistently confirming that there was no prospect of recovery.
After evaluating the findings of both the Primary Medical Board and the Secondary Medical Board, which unanimously concluded that the treatment had no therapeutic benefit, the Court permitted the withdrawal of life-sustaining treatment. The decision was also supported by Rana’s parents, who had cared for their son with remarkable devotion for thirteen years. The Court directed that the process be carried out in a palliative care environment with dignity and compassion.
Beyond the individual tragedy, the judgment marks a defining moment in India’s evolving jurisprudence on end-of-life care. For the first time, the Supreme Court has operationalised the procedural framework laid down in the Constitution Bench judgment in Common Cause v. Union of India (2018), which recognised that the right to live with dignity under Article 21 of the Constitution also includes the right to die with dignity. That landmark decision introduced the concept of advance medical directives and permitted passive euthanasia under carefully regulated conditions. The procedural requirements were further simplified in 2023 to make them more workable in practice.
At the heart of the Court’s reasoning lies the “best interests of the patient” principle. The Court emphasised that decisions about withdrawal of treatment must not be mechanical or purely medical. They require a holistic assessment of both medical and non-medical factors.
The constitutional promise of life under Article 21 cannot be interpreted in isolation from the realities of terminal illness. In many cases, patients spend years trapped in irreversible medical conditions, deprived of autonomy and human interaction, while their families endure immense emotional and financial strain. Parents, spouses and loved ones who witness the prolonged decline of someone they cherish often carry a burden that is both psychological and existential.
The Court also issued important institutional directions to ensure transparency and uniformity. It directed that life support be withdrawn under a structured medical plan in a palliative care facility and asked High Courts across the country to instruct judicial magistrates to receive intimations from hospitals when medical boards unanimously recommend withdrawal of life support. The Union government was further directed to maintain district-level panels of registered medical practitioners to constitute secondary medical boards.
Despite these advances, the judgment once again highlights a persistent legislative vacuum. India’s approach to euthanasia has largely evolved through judicial pronouncements rather than through a comprehensive statutory framework. The issue first came before the Supreme Court of India in the landmark case of Aruna Shanbaug v. Union of India (2011). While the Court ultimately refused permission for euthanasia in that case however, it delivered a historic ruling by recognising that passive euthanasia could be permitted in India under carefully prescribed safeguards and with the approval of the Hon’ble High Court concerned. The Law Commission of India had earlier examined the issue in its 196th Report (2006) and reiterated its recommendations in the 241st Report (2012), urging Parliament to enact a comprehensive law governing the withdrawal of life-sustaining treatment.
India still lacks a comprehensive statutory framework on end-of-life care. The absence of legislation creates uncertainty for hospitals, doctors and families. Medical professionals often hesitate to withdraw life-sustaining treatment even when recovery is medically impossible, fearing potential legal consequences. Instead of relying on clear statutory guidance, they must navigate complex procedural guidelines derived from judicial decisions. A carefully drafted law could address several critical aspects. It could clearly define the circumstances in which withdrawal or withholding of treatment is permissible, specify the composition and functioning of medical boards, recognise advance medical directives or living wills and provide legal protection for doctors acting in good faith in accordance with established procedures.
One particularly sensitive concern relates to the potential misuse of passive euthanasia in connection with organ transplantation. India already faces significant challenges in regulating organ transplants and preventing illegal organ trade. Given the persistent shortage of legally available organs, the possibility that financial incentives might intersect with end-of-life decisions cannot be ignored.
For such reasons, any legal framework must create a clear and impermeable separation between the process of withdrawing life support and the process of organ donation. Strong safeguards would be essential to prevent misuse and the legislation must include strict verification procedures, independent medical assessments and transparent oversight mechanisms to ensure that decisions are genuinely taken in the patient’s best interests and documented, independently verified and subjected to rigorous review before any discussion of organ transplantation even arises. Without such safeguards, vulnerable patients may face subtle pressures that compromise genuine consent.
END OF ARTICLE
